Thu, Dec 18, 2014, 1:37 PM EST - U.S. Markets close in 2 hrs 23 mins


% | $
Quotes you view appear here for quick access.

Zumiez, Inc. Message Board

rickn27 7 posts  |  Last Activity: 23 hours ago Member since: Apr 8, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • This sell down looks like a knee-jerk response of traders to buzz words "pricing offering". But in fact, there's no dilution of the shares of CNDO, so there's no reason for any selling. Insider buying says the company's fortunes are turning for the better.

    Sentiment: Strong Buy

  • Reply to

    Piper Jaffray

    by investormdpart2 Dec 2, 2014 11:10 AM
    rickn27 rickn27 Dec 2, 2014 12:20 PM Flag

    where's the link to the article?

  • small enough to not look like - whoa, what do they know? Large enough to trigger a decent shortcovering. ER was good, Rev's good, Big rise over last year - PE is low; what's not to like? It already backed off from highs - I don't see any reason to hold if I were a short. Unless somehow they know inside info. All the public info says - hey, I hoped for a bad ER and I didn't get it. Cover and move on.....

    Sentiment: Buy

  • and probably more, since that data in perhaps a month old and the stock price had continued to fall. Only a small fraction of that has been covered so far today, I'd expect a final panic short-covering as we get towards the end of the day. At the very least, the previous resistance at 19 ought to be challenged. Ebola may or may not be contained in the U.S., but it certainly is not in West Africa.

  • "6 out of 14 patients had HCV RNA levels below the limit of quantification at day 29 and the 3 patients from this group who have reached day 57 still have HCV RNA levels below the limit of quantification.

    In other words, the virus comes back. Given this isn't phase 3, but only 'proof of concept', this 300% rise seems unwarranted. What about the other HepC companies who are closer to market?

  • rickn27 by rickn27 Oct 10, 2014 5:10 PM Flag

    profile usn't obviosly related to ebola. can;t find any news.

  • .... was sobering. Official with the US government made a strong case that the number of deaths and the percentages of death in Africa are under estimated. Also, the doubling time for new cases is 21 days, conservatively. Even if the one case in the U.S. might or might not be a genuine concern, TKMR's drug is acknowledged as the first which will come to use. Even if it does indeed take a year, as the post which seems to have tanked the stock late in the day suggests, by then there will be a strong demand in Africa alone. I wonder if that post was designed to allow accumulation tomorrow at better prices?

37.74+0.29(+0.77%)1:35 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.